Skip to main content
SpringerLink
Log in

Biobanking for Public Health

  • Conference paper
  • First Online:
Trust in Biobanking

Abstract

Genome-based biobanking requires a new governance model which integrates the personal values of the people concerned, the medical knowledge necessary to define a “genomic indication” as well as the procedural law which enables those professions and families involved to make an ethically and legally acceptable prioritisation of dissenting interests in genomic services and data. Thus, almost all healthcare systems are currently facing fundamental challenges. New ways of organizing these systems based on genomic health information and technologies and stakeholders’ different needs are essential to meet these challenges in time.

The issue of biobanking has become a specific challenge having major implications for future research and policy strategies as well as for the healthcare systems in general. The various stakeholders in public health play a key role in translating the implications of genome-based research deriving from biobanks for the benefit of population health. In setting the epidemiological research agenda, in balancing individual and social concerns, by promoting meaningful communication about genomics among researchers, professionals, policymakers, public health agencies, and the public, public health organizations will enhance the potential return on public investment in genomic research. Whereas medicine is currently undergoing remarkable developments from its morphological and phenotype orientation to a molecular and genotype orientation, promoting the importance of prognosis and prediction, the discussion about the role of genome-based biobanking for public health still is at the beginning.

The following chapter contributes to this discussion by focussing on the use of genome-based biobanking for public health research, surveillance systems, health policy development, individual health information management and effective health services.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • AETMIS (Agence d’evaluation des technologies et des modes d’intervention en sante) (2003) Health Technology Assessment in Genetics and Policy-making in Canada : Towards a sustainable development. Report from a symposium held September 11th and 12th, 2003 in Montreal,

    Google Scholar 

  • Annas GJ (2000) Rules for Research on Human Genetic Variation – Lessons from Iceland. N Engl J Med 342: 1830-1833

    Google Scholar 

  • Antonovsky A (1987) Unraveling the mystery of health. How people manage stress and stay well. Jossey Bass, San Francisco

    Google Scholar 

  • ARIC investigators (1989) The Atherosclerosis Risk in Communities (ARIC) Study: Design and objectives. Am J Epidemiol 129: 687-702

    Google Scholar 

  • Banta HD, Luce BR (1993) Health Care Technology and its Assessment. An International Perspective. Oxford University Press, Oxford et al

    Google Scholar 

  • Baird PA (2000) Identification of genetic susceptibility to common diseases: the case for regulation. Perspect Biol Med 45: 516-528

    Google Scholar 

  • Barabasi AL (2007) Network Medicine – From Obesity to the “Diseasome”. N Engl J Med 357: 1866-1868

    Google Scholar 

  • Beskow LM et al (2001) The Integration of Genomics into Public Health Research, Policy and Practice in the United States. Community Genet 4: 2-11

    Google Scholar 

  • Bosch X (2006) Group Ponders Genomics and Public Health. JAMA 295: 1762

    Google Scholar 

  • Brand A (2002a) Prädiktive Gentests – Paradigmenwechsel für Prävention und Gesundheitsversorgung? Gesundheitswesen 64: 224-229

    Google Scholar 

  • Brand A (2002b) Health Technology Assessment als Basis einer Prioritätensetzung. In Fozouni B, Güntert B (eds) Prioritätensetzung im deutschen Gesundheitswesen. Logos Verlag, Berlin

    Google Scholar 

  • Brand A (2005) Public health and genetics – dangerous combination? View-point section. Eur J Public Health 15:113-116

    Google Scholar 

  • Brand A, Brand H (2005) Public Health Genetics – Challenging “Public Health at the Crossroads”. Ital J Public Health 2: 59

    Google Scholar 

  • Brand A, Dabrock P, Paul N et al (2004) Gesundheitssicherung im Zeitalter der Genomforschung – Diskussion, Aktivitäten und Institutionalisierung von Public Health Genetics in Deutschland. Gutachten zur Bio- und Gentechnologie. Friedrich-Ebert-Stiftung, Berlin

    Google Scholar 

  • Burke W (2003) Genomics as a Probe for Disease Biology. N Engl J Med 349: 969-974

    Google Scholar 

  • Childs B, Valle D (2000) Genetics, Biology and Disease. Ann Rev Gen Hum Genet 1: 1-19

    Google Scholar 

  • Collins FS, McKusick VA (2001) Implications of the Human Genome Project for Medical Science. J Am Med Ass 285: 540-544

    Google Scholar 

  • Collins FS, Patrinos A, Jordan E et al (1998) New Goals for the U.S. Genome Project: 1998-2003. Science 282: 682-689

    Google Scholar 

  • Coughlin S (2006) Ethical issues in epidemiologic research and public health practice. BioMed Central Open Access. Emerging themes in Epidemiology 3

    Google Scholar 

  • Coulter A, Jenkinson C (2005) European patients’ views on the responsiveness of health systems and healthcare providers. Eur J Public Health 15: 355-360

    Google Scholar 

  • Daar AS (2002) Top 10 biotechnologies for improving health in developing countries. Nat Genet 32: 229-232

    Google Scholar 

  • Dorman JS, Mattison DR (2000) Epidemiology, Molecular Biology and Public Health. In Khoury MJ, Burke W, Thomson EJ (eds.) Genetics and Public Health in the 21st Century. Using Genetic Information to Improve Health and Prevent Disease. Oxford University Press, Oxford et al

    Google Scholar 

  • Ellsworth DL, O’Donnell CJ (2004) Emerging Genomic Technologies and Analytic Methods for Population- and Clinic-Based Research. In Khoury MJ, Little J, Burke W (eds) Human Genome Epidemiology. A Scientific Foundation for Using Genetic Information to Improve Health and Prevent Disease. Oxford University Press, Oxford et al

    Google Scholar 

  • Erikson JM, Kivnick HQ (1986) Vital involvement in old ages. Norton, New York

    Google Scholar 

  • European Science Foundation (2008) Population Surveys and Biobanking. Science Policy Briefing. www.esf.org. Accessed 20 May 2008

    Google Scholar 

  • Eylenbosch WJ, Noah ND (1988) Historical aspects. In: Eylenbosch WJ, Noah ND (eds) Surveillance in health and disease. Oxford University Press, Oxford

    Google Scholar 

  • Frankish CJ, Kwan B, Ratner PA et al (2002) Challenges of citizen participation in regional health authorities. Soc Sci Med 54: 1471-1480

    Google Scholar 

  • French ME, Moore JB (2003) Harnessing Genetics to Prevent Disease and Promote Health. Partnership for Prevention. Washington

    Google Scholar 

  • Geier M, Schröder P (2003) The Concept of Human Dignity in Biomedical Law. In Sándor J, den Exter AP (eds) Frontiers of European Health Law: A Multidisciplinary Approach. Erasmus University Press-DocVision, Delft

    Google Scholar 

  • Gibbs RA, Belmont JW, Hardenbol P (2003) The International HapMap Project. Nature 426: 789-796

    Google Scholar 

  • Gostin LO (2001) Health information: reconciling personal privacy with the public good of human health. Health Care Anal 9: 321-335

    Google Scholar 

  • Gutteling J, Hanssen L, van der Veer N et al (2006) Trust in governance and acceptance of genetically modified food in the Netherlands. Public Underst Sci 15: 103-112

    Google Scholar 

  • Guttmacher AE, Collins FS (2002) Genomic Medicine – A Primer. N Engl J Med 347: 1512-1521

    Google Scholar 

  • Gwinn M, Khoury MJ (2006) Genomics and Public Health in the United States: Signposts on the Translation Highway. Community Genet 9: 21-26

    Google Scholar 

  • Hakonarson H, Gulcher JR, Stefansson K (2003) decode Genetics, Inc. Pharmacogenomics 4: 209-215

    Google Scholar 

  • Hansen L, Gutteling JM, Lagerwerf L et al (2001) In the Margins of the Public Debate on “Food and Genes“: Research under Commission of the Committee Biotechnology and Food. Twente University, Enschede

    Google Scholar 

  • Hoos A, Urist MJ, Stojadinovic A et al (2001)Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroplastic tumors. Am J Pathol 158: 1245-1251

    Google Scholar 

  • Kettis-Lindblad A, Ring L, Viberth E, Hansson MG (2005) Genetic research and donation of tissue samples to biobanks. What do potential sample donors in the Swedish general public think? Eur J Public Health 16: 433-440

    Google Scholar 

  • Khoury MJ (1996) From Genes to Public Health: The Applications of Genetic Technology in Disease Prevention. Am J Public Health 86: 1717-1722

    Google Scholar 

  • Khoury MJ (1997) Relationship Between Medical Genetics and Public Health: Changing the Paradigm of Disease Prevention and the Definition of a Genetic Disease. Am J Med Gen 17: 289-291

    Google Scholar 

  • Khoury MJ, Burke W, Thomson E (2000) Genetics in Public Health: A Framework for the Ingegration of Human Genetics into Public Health Practice. In Khoury MJ, Burke W, Thomson EJ (eds) Genetics and Public Health in the 21st Century. Using Genetic Information to Improve Health and Prevent Disease. Oxford University Press, Oxford et al

    Google Scholar 

  • Khoury MJ, Little J, Burke W (2004) Human genome epidemiology: scope and strategies. In: Khoury MJ, Little J, Burke W (eds.) Human Genome Epidemiology. Oxford University Press, New York

    Google Scholar 

  • Khoury MJ, Millikan R, Little J et al (2004) The emergence of epidemiology in the genomics age. Int J Epidemiol 33: 936-944

    Google Scholar 

  • Knoppers BM (2005) Of genomics and public health: Building public “goods”? Can Med Assoc J 173: 1185-1186

    Google Scholar 

  • Kononen J, Bubendorf L, Kallioniemi A et al (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844-847

    Google Scholar 

  • Lai E, Bansal A, Hughes A (2002) Medical applications of haplotype-based SNP maps: learning to walk before we run. Nat Genet 32: 353

    Google Scholar 

  • Langmuir AD (1963) The surveillance of communicable diseases of national importance. N Engl J Med 268:182-192

    Google Scholar 

  • Little J (2004) Reporting and Review of the Human Genome Epidemiology Studies. In: Khoury MJ, Little J, Burke W (eds) Human Genome Epidemiology. A Scientific Foundation for Using Genetic Information to Improve Health and Prevent Disease. Oxford University Press, Oxford et al

    Google Scholar 

  • Loscalzo J, Kohane I, Barabasi AL (2007) Human disease classification in the postgenomic era: A complex systems approach to human pathobiology. Mol Syst Biol 3: 124

    Google Scholar 

  • Lunshof JE, Chadwick R, Vorhaus DB et al (2008) From genetic privacy to open consent. Nat Rev Genet 9: 406-411

    Google Scholar 

  • Michigan Center for Genomics and Public Health (2004) Ethical, Legal and Social Issues in Public Health Genetics (PHELSI), http://www.sph.umich.edu/genomics/media/subpage_autogen/PHELSI.pdf. Accessed 15 July 2008

    Google Scholar 

  • Moldrup C (2002) Medical Technology Assessment of the Ethical, Social, and Legal Implications of Pharmacogenomics. A research Proposal for an Internet Citizen Jury. Int J Technol Assess Health Care 18: 728-732

    Google Scholar 

  • Motter AE, Gulbahoe N, Almaas E et al (2008) Predicting synthetic rescues in metabolic networks. Mol Syst Biol 4: 168

    Google Scholar 

  • Omenn GS (2000) Public health genetics: an emerging interdisciplinary field for the postgenomic era. Ann Rev Public Health 21: 1-13

    Google Scholar 

  • O’Neill O (2002) Autonomy and Trust in Bioethics. Cambridge University Press, Cambridge

    Google Scholar 

  • Peltonen L, McKusick VA (2001) Genomics and Medicine. Dissecting Human Disease in the Postgenomic Era. Science 291: 1224-1229

    Google Scholar 

  • Perleth M (2003) Evidenzbasierte Entscheidungsunterstützung im Gesundheitswesen. Konzepte und Methoden der systematischen Bewertung medizinischer Technologien (Health Technology Assessment) in Deutschland. Verlag für Wissenschaft und Kultur, Berlin

    Google Scholar 

  • Pollitt RJ, Green A, McCabe CJ (1997) Neonatal screening for inborn errors of metabolism: cost, yield and outcome. Boldrewood, The National Coordinating Centre for Health Technology Assessment (NCCHTA)

    Google Scholar 

  • Probst-Hensch NM, Ingles SA, Diep AT et al (1999) Aromatase and breast cancer susceptibility. Endocr Relat Cancer 6(2):165-173

    Google Scholar 

  • Sass HM (2001) A ‘Contract Model’ for Genetic Research and Health Care for Individuals and Families. Eubios J Asian Int Bioeth 11: 130-132

    Google Scholar 

  • Schröder P (2004) Gendiagnostische Gerechtigkeit. Eine ethische Studie über die Herausforderungen postnataler genetischer Prädiktion. LIT Verlag, Münster et al

    Google Scholar 

  • Schröder P (2007) Public Health Ethik in Abgrenzung zur Medizinethik. Bundesgesundheitsbl – Gesundheitsforsch – Gesundheitsschutz 50: 103-111

    Google Scholar 

  • Seigel D (2003) Clinical trials, epidemiology, and public confidence. Stat Med 22: 19-25

    Google Scholar 

  • Shani S, Siebzehner MI, Luxenburg O (2000) Setting priorities for the adoption of health technologies on a national level – the Israeli experience. Health Policy 54: 169-185

    Google Scholar 

  • Sing CF, Stengard JH, Kardia SL (2003) Genes, environment, and cardiovascular disease. Art Thromb Vasc Biol 23: 1950

    Google Scholar 

  • Smith GD, Ebrahim S, Lewis S et al (2005) Genetic epidemiology and public health: hope, hype, and future prospects. Lancet 366: 1484-1498

    Google Scholar 

  • Tauber AI (2003) Sick Autonomy. Perspect Biol Med 46: 484-495

    Google Scholar 

  • Torhorst J, Bucher C, Kononen J (2001) Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 159: 2249-2256

    Google Scholar 

  • UNESCO (2003) International Declaration on Human Genetic Data. Paris

    Google Scholar 

  • Walt G (1994) Health Policy: An Introduction to Process and Power. Zed Books, London New Jersey

    Google Scholar 

  • Williams G (2005) Bioethics and large-scale biobanking: individualistic ethics and collective projects. Genomics Soc Policy 1: 50-66

    Google Scholar 

  • Wright AF, Carothers AD, Campbell H (2002) Gene-environment interactions – the BioBank UK study. Pharmacogenomics 2: 275-282

    Google Scholar 

  • Yoon PW (2001) Public health impact of genetic tests at the end of the 20th century. Genet Med 3: 405-410

    Google Scholar 

  • Zimmern R, Cook C (2000) Genetics and Health. Policy issues for genetic science and their implications for health and health services. The Nuffield Trust Genetics Scenario Project. The Nuffield Trust, London

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Maastricht, Maastricht, The Netherlands

    Angela Brand MD, PhD & Tobias Schulte

  2. Centre for Clinical Research, University of Zurich, Zurich, Switzerland

    Nicole M. Probst-Hensch PhD

Authors
  1. Angela Brand MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tobias Schulte
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nicole M. Probst-Hensch PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Erlangen-Nuremberg, Chair for Systematic Theology / Ethics, Friedrich-Alexander University, Kochstraße 6, Erlangen, 91056, Germany

    Peter Dabrock

  2. , Institute for Medical and Health Law, University of Mannheim, Schloss, Westflügel, Mannheim, 68131, Germany

    Jochen Taupitz

  3. Erlangen-Nuremberg, Chair for Systematic Theology / Ethics, Friedrich-Alexander-University, Kochstraße 6, Erlangen, 91056, Germany

    Jens Ried

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Brand, A., Schulte, T., Probst-Hensch, N.M. (2012). Biobanking for Public Health. In: Dabrock, P., Taupitz, J., Ried, J. (eds) Trust in Biobanking. Veröffentlichungen des Instituts für Deutsches, Europäisches und Internationales Medizinrecht, Gesundheitsrecht und Bioethik der Universitäten Heidelberg und Mannheim, vol 33. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-78845-4_1

Download citation

Publish with us

Policies and ethics

Search

Navigation